Skip to content
Dose Brief
Menu

SkinnyRx review

By Updated

A provider that puts every term and every rate on the page before a single medical question — and then advertises itself with the twelve-month rung of each one, on a microdose line that costs the same as the full dose.

Brief Score58/100Grade CNo. 356 in our directory
Visit SkinnyRx We may earn a commission through this link at no extra cost to you. It does not change our score.

On the record

The FDA issued a warning letter to Lean Rx, Inc. dba SkinnyRx in February 2026. Read the letter in the FDA's warning letter database for the agency's findings.

Semaglutide

$349/mo month-to-month, compounded — the advertised $199 is the 12-month rung, billed as $2,388 in one payment

Tirzepatide

$399/mo month-to-month, compounded, injection or tablet at the same price — the advertised $299 is the 12-month rung, billed as $3,588 in one payment

Coverage
47 states + Washington DC — not Alabama, Louisiana or Mississippi
Brand-name
Not confirmed

Prices checked against SkinnyRx's published terms in . Providers change pricing without notice — check the current figure before you buy.

On the trackerNewnew to the tracker, no prior reading— Month-to-month prices are $349 for semaglutide and $399 for tirzepatide; the tirzepatide tablet has the same price as the injection. The $199/$299 monthly equivalents require annual prepayment of $2,388/$3,588 and automatic annual renewal.

SkinnyRx in depth

SkinnyRx advertises itself at "as low as $199" for semaglutide and $299 for tirzepatide, and both figures are the twelve-month rung. Read out of the site's own price chunk on August 8, 2026, semaglutide injection runs $349 for one month, $299 on four, $249 on six and $199 on twelve; tirzepatide runs $399, $349, $329 and $299. Nothing on the page is discounted down to the headline over time — the headline simply is the longest term.

What that term costs is the part worth pausing on. The checkout charges the monthly rate multiplied by the number of months on day one, so $199 is $2,388 taken at once and $299 is $3,588, and the plan auto-renews annually for the same amount. Affirm financing appears on the page only once the term runs past a single month — that is, only on the plans that require the lump sum, which is a fair signal of how large the charge is.

Two findings here are unusual enough to state plainly. The tablet costs exactly what the injection costs, at all four terms — a needle-free route with no premium attached is rare, and if you would rather not inject, you are not paying for the preference.

The second cuts the other way. The microdose line costs the same as the full dose at every shared term, and its cheapest rate is HIGHER than the full-dose one — $229 against $199 on semaglutide, $319 against $299 on tirzepatide — because the microdose plans stop at eight months rather than twelve. You would be paying more money for less drug. Microdosing has its advocates, but the pricing here gives no financial reason to choose it.

One price we will not print. The "Compounded Sublingual Semaglutide" tile displays $199, while the commerce entry behind it maps to the tirzepatide ladder. We do not know which of the two that product actually charges, and guessing at a price is worse than saying so — ask before you buy that specific route.

SkinnyRx's operator, Lean Rx, Inc., received an FDA warning letter in February 2026. Read the agency’s findings alongside the plan terms and medication information, including the flat tablet pricing and a microdose option priced above the full-dose option.

The scorecard

SkinnyRx scored on our six Brief Score factors. See the methodology.

Price Stability54/100
Supply Reliability58/100
Transparency62/100
Access Breadth74/100
Clinical Oversight55/100
Track Record42/100

What we like

  • Every term and every rate is on the product page before any medical intake — four rungs per SKU, both molecules, both routes — which is more than most of this ranking publishes anywhere
  • The tirzepatide tablet is priced identically to the tirzepatide injection at all four terms, so choosing the needle-free route costs nothing extra here
  • Names the three states it does NOT serve — Alabama, Louisiana and Mississippi — instead of the "select states" most providers say, so a reader can check coverage in one glance
  • A separate low-dose line with its own page and its own intake, for readers who titrate badly at therapeutic doses
  • Concrete terms rather than vague ones: free shipping, unlimited provider messaging, a 90-day money-back guarantee, and no charge at all if a clinician finds you ineligible
  • Both molecules by both routes on one account, so switching route does not mean switching providers

The caveats

  • Every "as low as" figure on the site is a twelve-month rate: $199 semaglutide bills $2,388 in one payment and $299 tirzepatide bills $3,588, each auto-renewing annually. Month-to-month you pay $349 and $399, and the financing option only appears once the term is longer than a month
  • The microdose line costs the SAME as full dose at every term it shares — $349 and $399 month-to-month, $299 and $349 at four months — and its floor is HIGHER, $229 against $199 and $319 against $299, because it stops at eight months instead of twelve. More money for less drug
  • One published price cannot be trusted: the "Compounded Sublingual Semaglutide" tile displays $199 while its checkout price maps to the tirzepatide ladder, so we publish no sublingual semaglutide figure at all rather than guess which one it charges
  • No brand-name route is actually purchasable. Ozempic, Wegovy, Wegovy Pill, Foundayo Pill, Mounjaro and Zepbound all carry no price at checkout and both pills read as out of stock; the only priced brand path is a $49/mo membership "+ Medication Cost", and that medication cost is published nowhere
  • The dispensing pharmacies are never named — only "503A pharmacies" — and no medical director or prescriber is identified anywhere on the consumer pages
  • Compounded semaglutide and tirzepatide are not FDA-approved products, and this provider sells nothing that is
  • FDA issued a warning letter in February 2026 to the company behind this provider; it is disclosed on every surface that ranks it and has not been closed out

The brief

Best for: Readers who will not inject and want a tablet at no premium over the injection, and who will check which term a "$199" is attached to before treating it as a monthly bill. A provider that puts every term and every rate on the page before a single medical question — and then advertises itself with the twelve-month rung of each one, on a microdose line that costs the same as the full dose.

Ranked #356 of 546 providers we reviewed — compare with CoreAge Rx, for comparison.

Before you decide

The questions readers ask next after reading about SkinnyRx.

Closest here

The providers scoring nearest SkinnyRx — read each current assessment before choosing care.

Weighing SkinnyRx against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs SkinnyRx, and every provider that outranks it is listed on the SkinnyRx alternatives ranking.

More providers we track (24)

514 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect SkinnyRx's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on SkinnyRx's site. Not medical advice; see our disclosure.

← Back to all rankings